## **Core Concept**
Carcinoembryonic antigen (CEA) is a tumor marker commonly associated with various types of cancers, particularly colorectal carcinoma. It belongs to a family of immunoglobulin-like glycoproteins and is used clinically to monitor disease progression and response to treatment.

## **Why the Correct Answer is Right**
CEA is indeed a marker for carcinoma, especially colorectal cancer. Elevated levels of CEA can indicate recurrence or metastasis of the disease. It is also used in monitoring the effectiveness of treatment. CEA levels are not specific to colorectal cancer and can be elevated in other types of cancers and non-cancerous conditions. However, its utility as a tumor marker for monitoring and follow-up is well established.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not specify a known tumor marker.
- **Option B:** This option is incorrect because it does not accurately represent a commonly recognized marker for carcinoma.
- **Option D:** This option is incorrect because it does not correspond to a well-established tumor marker for carcinomas.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while CEA is a useful marker for monitoring colorectal cancer, it is not diagnostic on its own due to its elevation in various other conditions. A significant rise in CEA levels over time can indicate recurrence or metastasis.

## **Correct Answer:** C. CEA (Carcinoembryonic Antigen).